Dr. Jain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 Waterstone Dr
Hillsborough, NC 27278Phone+1 919-966-8596Fax+1 919-843-6949
Summary
- Dr. Animesh Jain is a gastroenterologist in Hillsborough, NC and is affiliated with University of North Carolina Hospitals. He received his medical degree from University of Virginia School of Medicine and has been in practice 8 years. He specializes in inflammatory bowel disease and is experienced in inflammatory bowel disease, ulcerative colitis, crohn's disease, and pancreatic cancer. He has more than 10 publications and over 150 citings.
Education & Training
- East Carolina UniversityMAED, Education, 2018 - 2023
- Johns Hopkins UniversityFellowship, Gastroenterology, 2012 - 2015
- NYU Grossman School of MedicineResidency, Internal Medicine, 2009 - 2012
- University of Virginia School of MedicineClass of 2009
Certifications & Licensure
- NC State Medical License 2015 - 2025
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- What's UP with Ulcerative Proctitis?: It's Not Always What You Think.Gabrielle Ritaccio, Millie D Long, Animesh Jain, Hans H Herfarth, Edward L Barnes
Digestive Diseases and Sciences. 2024-03-01 - Lower Extremity Palpable Purpura in a Patient with Quiescent Inflammatory Bowel Disease.Kimberly Darlington, Paul Googe, Priyanka Vedak, Animesh Jain, Millie D Long
Digestive Diseases and Sciences. 2023-07-01 - The political, religious and human impact of COVID-19: what did it cost us?Matthew Antony Manoj, Animesh Jain
Rural and Remote Health. 2023-03-01
Press Mentions
- Five New Faculty Members Join Office of Academic Excellence to Provide Student SupportJune 3rd, 2021
- Colonic Ulcerations May Predict Steroid-Refractory Course in Patients with Ipilimumab-Mediated EnterocolitisApril 11th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: